Belumosudil with ROCK-2 inhibition: a new drug for the treatment of chronic graft-versus-host Disease

doi:10.3969/j.issn.1672-3384.2023.03.004

PDF(407 KB)

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (3) : 18-22. DOI: 10.3969/j.issn.1672-3384.2023.03.004

Comment of New Drug

Belumosudil with ROCK-2 inhibition: a new drug for the treatment of chronic graft-versus-host Disease

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 21(3): 18-22 https://doi.org/10.3969/j.issn.1672-3384.2023.03.004

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(407 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2022-11-30	2023-03-27
Issue Date
2023-03-27

Please choose a citation manager

Content to export